Johnson and Johnson Archives

Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.

Contineum’s test drug may reverse multiple sclerosis damage

Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.

by HealthQuill
August 6, 2024
0 Comments

British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a standard-of-care combination, according to the company.

Drugs Health Pharma

GSK’s blood cancer test drug halves risk of disease progression: Data

British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a.

by HealthQuill
June 3, 2024
0 Comments

The WHO has sounded a global alert on a batch of substandard cough syrup found in Cameroon, which has high levels of a toxic ingredient, diethylene glycol.

Drugs Medical Pharma

Six African nations recall J&J manufactured cough syrup after suspicious toxicity reports

HQ Team April 17, 2024: Drug regulatory authorities in South Africa, Tanzania, Rwanda, Nigeria, Kenya, Eswatini and Zimbabwe have issued a recall for.

by HealthQuill
April 17, 2024
0 Comments

The USFDA has granted accelerated approval to Janssen Pharmaceutical Companies for its cancer antibody treatment, Talvey, to treat multiple myeloma.

Drugs Health Pharma

USFDA green lights Janssen’s Talvey to treat multiple myeloma

HQ Team August 11, 2023: The USFDA has granted accelerated approval to Janssen Pharmaceutical Companies for its cancer antibody treatment, Talvey, to treat.